Logo

Myriad Genetics: Eric Santa, Jeff Borcherding

Mar 29, 2021

Myriad Genetics has hired Eric Santa, previously chief revenue officer at UnitedHealth Group's Rally Health, as its new chief growth officer. Santa will report to Myriad CEO Paul Diaz and lead marketing, digital, branding, and communications initiatives that grow the company's presence and reach. He will also spearhead efforts to glean new genetic insights using Myriad's patient database and identify expansion opportunties. 

Additionally, Jeff Borcherding, previously a general manager leading sales and marketing efforts for the GeneSight pharmacogenetic test, has been promoted to senior VP and chief marketing officer within Santa's team. Borcherding will now focus on increasing test volumes and revenues within Myriad's integrated product marketing initiatives.

Breaking News
The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.